• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

硫酸葡聚糖对因子XII的激活作用:一种因子XII检测方法的基础

Activation of factor XII by dextran sulfate: the basis for an assay of factor XII.

作者信息

Tankersley D L, Alving B M, Finlayson J S

出版信息

Blood. 1983 Aug;62(2):448-56.

PMID:6191802
Abstract

A system was developed for studying the activation of factor XII (Hageman factor) in the presence of dextran sulfate (DS). Salient features of the system included low ionic strength (0.08), low concentration of factor XII (approximately 1/10,000 that in normal plasma), and an excess of exogenous prekallikrein (PK). In this system, factor XII was rapidly converted to the 80,000 molecular weight (mol wt) form of factor XIIa (alpha-factor-XIIa). Once formed, the factor XIIa converted PK to kallikrein at a rate that was proportional to the amount of factor XII originally present in the incubation mixture. This system was used to construct a simple sensitive assay for factor XII in plasma and other biologic samples. The kallikrein produced was measured spectrophotometrically with the chromogenic substrate (H-D-Pro-Phe-Arg-p-nitroanilide (S-2302). This assay was shown to be independent of the high molecular weight kininogen and the PK content of the sample being analyzed. The measurements obtained were consistent with fundamental enzymologic principles and, if desired, could be processed with a simple calculator program to achieve linear standard curves. When applied to the quantitation of factor XII in plasma, the assay yielded values in close agreement with those determined by coagulant assay or by radial immunodiffusion.

摘要

开发了一种用于研究在硫酸葡聚糖(DS)存在下因子 XII(哈格曼因子)激活的系统。该系统的显著特点包括低离子强度(0.08)、低因子 XII 浓度(约为正常血浆中浓度的 1/10,000)以及过量的外源性前激肽释放酶(PK)。在该系统中,因子 XII 迅速转化为分子量 80,000 的因子 XIIa 形式(α-因子 XIIa)。一旦形成,因子 XIIa 以与孵育混合物中最初存在的因子 XII 量成比例的速率将 PK 转化为激肽释放酶。该系统用于构建一种简单灵敏的血浆和其他生物样品中因子 XII 的检测方法。用发色底物(H-D-脯氨酸-苯丙氨酸-精氨酸-对硝基苯胺(S-2302))通过分光光度法测定产生的激肽释放酶。该检测方法被证明与高分子量激肽原和被分析样品的 PK 含量无关。获得的测量结果符合基本的酶学原理,并且如果需要,可以用简单的计算器程序进行处理以获得线性标准曲线。当应用于血浆中因子 XII 的定量时,该检测方法得到的值与通过凝血检测或放射免疫扩散测定的值非常一致。

相似文献

1
Activation of factor XII by dextran sulfate: the basis for an assay of factor XII.硫酸葡聚糖对因子XII的激活作用:一种因子XII检测方法的基础
Blood. 1983 Aug;62(2):448-56.
2
The contact activation mechanism in human plasma: activation induced by dextran sulfate.人血浆中的接触激活机制:硫酸葡聚糖诱导的激活。
Blood. 1982 Jun;59(6):1225-33.
3
Mechanism of surface-mediated activation of bovine Factor XII and prekallikrein.表面介导的牛因子XII和前激肽释放酶激活机制。
Adv Exp Med Biol. 1983;156:87-107.
4
Kinetic studies on surface-mediated activation of bovine factor XII and prekallikrein. Effects of kaolin and high-Mr kininogen on the activation reactions.表面介导的牛因子XII和前激肽释放酶激活的动力学研究。高岭土和高分子量激肽原对激活反应的影响。
Eur J Biochem. 1985 Jan 2;146(1):43-50. doi: 10.1111/j.1432-1033.1985.tb08617.x.
5
Initiation of contact system activation in plasma is dependent on factor XII autoactivation and not on enhanced susceptibility of factor XII for kallikrein cleavage.血浆中接触系统激活的起始依赖于因子 XII 的自身激活,而非因子 XII 对激肽释放酶裂解的易感性增强。
Br J Haematol. 1997 Oct;99(1):197-205. doi: 10.1046/j.1365-2141.1997.3513165.x.
6
Activation of factor XII and prekallikrein with polysaccharide sulfates and sulfatides: comparison with kaolin-mediated activation.用多糖硫酸盐和硫脂激活因子XII和前激肽释放酶:与高岭土介导的激活作用的比较。
J Biochem. 1985 Feb;97(2):429-39. doi: 10.1093/oxfordjournals.jbchem.a135077.
7
Plasma prekallikrein: quantitative determination by direct activation with Hageman factor fragment (beta-XIIa).血浆前激肽释放酶:通过与哈格曼因子片段(β - XIIa)直接激活进行定量测定。
J Lab Clin Med. 1983 Feb;101(2):226-41.
8
Dextran sulphate inhibits phospholipid and sulphatide mediated autoactivation of factor XII.硫酸葡聚糖抑制磷脂和硫脂介导的因子 XII 自身激活。
Blood Coagul Fibrinolysis. 1994 Aug;5(4):503-9.
9
Detection of activation of the contact system of coagulation in vitro and in vivo: quantitation of activated Hageman factor-C-1-inhibitor and kallikrein-C-1-inhibitor complexes by specific radioimmunoassays.体外和体内凝血接触系统激活的检测:通过特异性放射免疫分析法对活化的哈格曼因子-C1-抑制剂和激肽释放酶-C1-抑制剂复合物进行定量分析。
Thromb Haemost. 1987 Aug 4;58(2):778-85.
10
Pathogenic mechanisms of bradykinin mediated diseases: dysregulation of an innate inflammatory pathway.缓激肽介导疾病的发病机制:固有炎症途径的失调。
Adv Immunol. 2014;121:41-89. doi: 10.1016/B978-0-12-800100-4.00002-7.

引用本文的文献

1
In vitro reconstitution of kallikrein-kinin system and progress curve analysis.体外重建激肽释放酶-激肽系统及进度曲线分析。
Biosci Rep. 2022 Oct 28;42(10). doi: 10.1042/BSR20221081.
2
Intrinsic Pathway of Coagulation and Thrombosis.凝血和血栓形成的内在途径。
Arterioscler Thromb Vasc Biol. 2019 Mar;39(3):331-338. doi: 10.1161/ATVBAHA.118.312130.
3
Factor XII as a Risk Marker for Hemorrhagic Stroke: A Prospective Cohort Study.凝血因子XII作为出血性中风的风险标志物:一项前瞻性队列研究。
Cerebrovasc Dis Extra. 2017;7(1):84-94. doi: 10.1159/000468994. Epub 2017 Apr 21.
4
Regulation of Complement and Contact System Activation via C1 Inhibitor Potentiation and Factor XIIa Activity Modulation by Sulfated Glycans - Structure-Activity Relationships.通过硫酸化聚糖增强C1抑制剂和调节因子XIIa活性对补体和接触系统激活的调控——构效关系
PLoS One. 2016 Oct 26;11(10):e0165493. doi: 10.1371/journal.pone.0165493. eCollection 2016.
5
Determination of C1s-C1 inhibitor complexes in plasma by means of an enzyme linked immunosorbent assay.通过酶联免疫吸附测定法测定血浆中的C1s-C1抑制剂复合物。
Clin Exp Immunol. 1985 Apr;60(1):178-82.
6
FXII.十二因子
Blut. 1990 Nov;61(5):258-66. doi: 10.1007/BF01732874.